1. Home
  2. A

as 05-17-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Founded: 1999 Country:
United States
United States
Employees: N/A City: SANTA CLARA
Market Cap: 43.9B IPO Year: 1999
Target Price: $140.41 AVG Volume (30 days): 1.6M
Analyst Decision: Buy Number of Analysts: 19
Dividend Yield: 0.61% Dividend Payout Frequency: Quarterly
EPS: 4.19 EPS Growth: -5.63
52 Week Low/High: $96.80 - $155.24 Next Earning Date: 05-29-2024
Revenue: $6,735,000,000 Revenue Growth: -2.81%
Revenue Growth (this year): 1.16% Revenue Growth (next year): 6.44%

Share on Social Networks:

Stock Insider Trading Activity of Agilent Technologies Inc. (A)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Binns Philip A Senior Vice President Mar 25 '24 Sell $147.54 2,827 $417,095.58 9,997 SEC Form 4
Binns Philip A Senior Vice President Dec 27 '23 Sell $139.78 2,880 $402,566.40 12,824 SEC Form 4